InsidersTradesSigma
株式会社メディパルホールディングス Stock: price and insider trades · Japan · EDINET (Japan FSA)
Track the 株式会社メディパルホールディングス share price and the full management transaction log of the company, a listed issuer based in Japan. Shares are listed on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社メディパルホールディングス has recorded 7 insider filings. Market capitalisation: €557bn. The latest transaction was disclosed on 6 August 2026 (Holding update). Among the most active insiders: Silchester International Investors LLP. Every trade is free.
7
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 株式会社メディパルホールディングス Hold (neutral), based on 4 analysts. Average price target: JP¥2,963.
20Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 12,915 of 28,204 companies
54.2
score / 100
Value79
Quality30
FCF yld6.4%
Earn yld7.3%
EV/EBITDA5.8x
ROE7.3%
Gross mgn6.8%
Net mgn1.1%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 August 2026
Declarations7 total
ShareXTKSEDINET:S100YUL7
ShareXTKSEDINET:S100Y49G
31.4% of flowShareXTKSEDINET:S100VEI8
0.061% mcap50.9% of flowShareXTKSEDINET:S100QJ3D
0.059% mcap49.1% of flowShareXTKSEDINET:S100PXPD
208,500 shares0.0002% mcap2.7% of flowShareXTKSEDINET:S100N6B6
6,971,525 shares0.0080% mcap97.3% of flowShareXTKSEDINET:S100MDQ1
7 of 7 declarations
About 株式会社メディパルホールディングス
Medipal Holdings Corporation is a Japanese company engaged in the distribution of pharmaceutical and medical products. It primarily operates in the healthcare and pharmaceutical sector.